Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Nov 08, 2019Nov 12, 2019Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$30$432,780-4.81%
Aug 12, 2019Aug 14, 2019Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$34.04$680,835-6.51%
Feb 25, 2019Feb 27, 2019Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$30$630,000-6.74%
Oct 01, 2018Oct 02, 2018Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$38.16$801,372-10.11%
Sep 18, 2018Sep 20, 2018Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$40$518,080-7.01%
Jul 02, 2018Jul 05, 2018Patterson Matthew R
CEO
SellAudentes Therapeutics, Inc.BOLD$39.55$3M-29.25%
May 21, 2018May 23, 2018Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$38.15$774,498-10.57%
Apr 02, 2018Apr 05, 2018Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$30.01$21,009-0.41%
Oct 02, 2017Oct 05, 2017Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$27.92$698,070-12.70%
Sep 15, 2017Sep 19, 2017Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$25.06$250,561-5.08%
Jul 12, 2017Jul 15, 2017Patterson Matthew R
Pres
CEO
SellAudentes Therapeutics, Inc.BOLD$20$300,059-7.43%